About Rexon Laboratories Limited
Data last updated:
Rexon Laboratories Limited is a public limited company based in Jalandhar, Punjab, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 05 July 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909PB1995PLC016718. Its GSTIN is 03AADCM3230A1ZF (Punjab).
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹1.41 Cr. It is led by directors including Rakesh Sharma (Managing Director) and Pankaj Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D5 Sports & Surgicalcomplex Kapurthala Road, Jalandhar, Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.74 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹2.15 Cr and EBITDA of ₹4 Lakh (EBITDA margin 31.4%). Revenue has declined at a compounded annual rate (CAGR) of 61% over five years.
As per MCA filings, the company has open charges of ₹40.45 Cr on record. Court records list 14 cases involving the company, including 11 filed by the company and 3 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rexonlaboratories.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressD5 Sports & Surgicalcomplex Kapurthala Road, Jalandhar, Punjab, India
- IndustryHealthcare, Medical Consumables & Supplies, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Rexon Laboratories Limited
Rexon Laboratories has one previous CIN (Corporate Identification Number): U24231PB1995PLC016718. The current CIN is U51909PB1995PLC016718, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909PB1995PLC016718 | Current |
| U24231PB1995PLC016718 | Previous |
Business Activity of Rexon Laboratories Limited
The main business activity of Rexon Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Rexon Laboratories Limited
Rexon Laboratories Limited is audited by SHIV GOURAV & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHIV GOURAV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rexon Laboratories Limited
Rexon Laboratories has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Sharma | Director | 06 Feb 2000 | 26 Years 8 Months | Current |
| Karan Sharma | Director | 05 Jan 2019 | 7 Years 9 Months | Current |
| Rakesh Sharma | Managing Director | 05 Jul 1995 | 31 Years 3 Months | Current |
| Vijay Bharat | Director | 29 Sep 2001 | 25 Years 0 Months | Current |
Financials of Rexon Laboratories Limited FY 2025 filings available
Rexon Laboratories Limited reported revenue of ₹12.74 Lakh (down 93% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rexon Laboratories Limited
Revenue has declined at a compounded annual rate (CAGR) of 61% over five years, including a 93% fall in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rexon Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.15 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rexon Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rexon Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rexon Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rexon Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2021 | Others | ₹1 Cr | Open |
| 15 Jul 2020 | Others | ₹1.5 Cr | Open |
| 02 Jul 2020 | Others | ₹55 Lakh | Open |
| 20 Apr 2020 | Others | ₹10 Lakh | Open |
| 20 Apr 2020 | Others | ₹1.9 Cr | Open |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Rexon Laboratories Limited
Employment history and EPFO contributions of people linked to Rexon Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Rexon Laboratories Limited
Rexon Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCM3230A1ZF | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Rexon Laboratories Limited
Rexon Laboratories Limited has 14 court cases on record: 11 filed by Rexon Laboratories, 3 filed against it. 2 cases are pending and 12 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 3 | 0 |
| High courts | 3 | 0 | 2 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jalandhar, Punjab | Civil suit | Filed by the company against Radiant Parenterals Limited | Disposed |
| High Court of Punjab and Haryana | Revision petition | Filed by the company against Geodis Overseas Private Limited | Disposed |
| High Court of Punjab and Haryana | Criminal miscellaneous application | Filed by the company against State of Punjab | Pending |
| High Court of Punjab and Haryana | Criminal miscellaneous application | Filed by the company against State of Punjab & Another | Pending |
| District court, Jalandhar, Punjab | Civil miscellaneous application | Filed by the company against Naresh Kumar Enterprises | Disposed |
Full case history
All 14 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Rexon Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rexon Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rexon Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rexon Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Rexon Laboratories Limited
Frequently Asked Questions about Rexon Laboratories Limited
Rexon Laboratories is an active public limited company based in Jalandhar, Punjab, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 05 July 1995 (31+ years old) and is registered under CIN U51909PB1995PLC016718.
Rexon Laboratories reported revenue of ₹12.74 Lakh for FY 2025 (down 93% YoY).
Rexon Laboratories has 4 current directors:
- Rakesh Sharma - Managing Director
- Pankaj Sharma - Director
- Karan Sharma - Director
- Vijay Bharat - Director
Rexon Laboratories reported a net loss of ₹2.15 Cr and EBITDA of ₹4 Lakh (EBITDA margin 31.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rexon Laboratories is -61% over five years. In the latest year (FY 2025) revenue fell 93%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rexon Laboratories is 03AADCM3230A1ZF, registered in Punjab.
The CIN (Corporate Identification Number) of Rexon Laboratories is U51909PB1995PLC016718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexon Laboratories has 14 court cases on record: 11 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Rexon Laboratories was incorporated on 05 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Chandigarh.